BCL2 and neoplasm: Multivariable Cox proportional hazards model of stromal cell FOXC1 and tumor cell pERK1‐2 expression, NCCN‐IPI risk group, cell of origin, and MYC/BCL2 double expression in DLBCL patients (n = 92).